<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Single nucleotide polymorphisms (SNPs) are the most common form of genetic variation </plain></SENT>
<SENT sid="1" pm="."><plain>We previously demonstrated that SNPs (rs1800734, rs749072, and rs13098279) in the MLH1 gene region are associated with MLH1 promoter island methylation, loss of MLH1 protein expression, and microsatellite instability (MSI) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients </plain></SENT>
<SENT sid="2" pm="."><plain>Recent studies have identified less CpG-dense "shore" regions flanking many CpG islands </plain></SENT>
<SENT sid="3" pm="."><plain>These shores often exhibit distinct methylation profiles between different tissues and matched <z:mpath ids='MPATH_458'>normal</z:mpath> versus <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells of patients </plain></SENT>
<SENT sid="4" pm="."><plain>To date, most epigenetic studies have focused on somatic methylation events occurring within <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e>; less is known of the contributions of peripheral blood cell (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PBC</z:e>) methylation to processes such as aging and <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>To address whether MLH1 methylation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PBCs</z:e> is correlated with <z:mp ids='MP_0002006'>tumorigenesis</z:mp> we utilized the Illumina 450 K microarrays to measure methylation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PBC</z:e> DNA of 846 healthy controls and 252 CRC patients from Ontario, Canada </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of a region of chromosome 3p21 spanning the MLH1 locus in healthy controls revealed that a CpG island shore 1 kb upstream of the MLH1 gene exhibits different methylation profiles when stratified by SNP genotypes (rs1800734, rs749072, and rs13098279) </plain></SENT>
<SENT sid="7" pm="."><plain>Individuals with <z:mp ids='MP_0002169'>wild-type</z:mp> genotypes incur significantly higher <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PBC</z:e> shore methylation than heterozygous or homozygous variant carriers (p&lt;1.1Ã—10(-6); ANOVA) </plain></SENT>
<SENT sid="8" pm="."><plain>This trend is also seen in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases (p&lt;0.096; ANOVA) </plain></SENT>
<SENT sid="9" pm="."><plain>Shore methylation also decreases significantly with increasing age in cases and controls </plain></SENT>
<SENT sid="10" pm="."><plain>This is the first study of its kind to integrate <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PBC</z:e> methylation at a CpG island shore with SNP genotype status in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases and controls </plain></SENT>
<SENT sid="11" pm="."><plain>These results indicate that CpG island shore methylation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PBCs</z:e> may be influenced by genotype as well as the <z:mpath ids='MPATH_458'>normal</z:mpath> aging process </plain></SENT>
</text></document>